In this downloadable slideset, Jordan J. Feld MD, MPH, Paul Y. Kwo, MD, and Stefan Zeuzem, MD, review key studies on the treatment of hepatitis C presented at the 2014 Annual Meeting of the European Association for the Study of the Liver.
Hepatitis C in the News Your source for hepatitis C-related news from around the web.
Not sure what to submit? Read our news guidelines first.
Belt was, many years ago, an intravenous drug user, which is almost certainly how she contracted hepatitis C. Now clean and sober for more than two decades, happily married and a devoted mother and grandmother, she's glad to rid herself of the last vestige of that lifestyle. […]
Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers suggest. The team analyzed liver and blood samples from hepatitis C patients taken before treatment, and found that fewer immune cells reached the livers of patients…
The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of inPractice Resources, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States…
Translational researchers tracked in real-time how virus replicates and how drug clears HCV from liver, plasma BUFFALO, N.Y. - As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.
Significant gaps in hepatitis C care identified in a new meta-analysis will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.
Hepatitis C is a disease that is caused by a virus that affects the liver. Even though the disease often doesn't produce symptoms, it can seriously damage the liver and can be fatal. An estimated 3.2 million Americans have Hepatitis C.
Hepatitis C is an infectious disease of the liver that is caused by the hepatitis C virus, a virus that may also attribute to both acute and chronic illnesses lasting from several weeks to a lifetime.
Up to 75% of those infected with hepatitis C might not be aware of their status, only finding out when they have already progressed to liver failure or liver cancer. There is hope yet for patients suffering from chronic hepatitis C.
More than 500,000 Californians are infected with hepatitis C, yet the vast majority of those infected don't realize it. Even though hepatitis C is the leading cause of catastrophic liver damage, cirrhosis and liver cancer, it's estimated that up to 75 percent of infected Americans do not even know they…